Product Information
LISINOPRIL 10 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0181 per EA under NDC 62135064231. Its NADAC has been published 153 times since Nov 1, 2023.
FDA first approved this application on Sep 15, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Chartwell RX LLCNDC
62135064231
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA212041FDA Approved
9/15/2020
TE Code
AB
On Market Since
9/15/2020
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL 10 MG TABLET has been published 153 times since Nov 1, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0181 per EA |
|---|---|
| All-time high | $0.0197 (Dec 13, 2023) |
| All-time low | $0.0156 (Jul 17, 2024) |
| 52-week high | $0.0190 |
| 52-week low | $0.0181 |
| Median price | $0.0184 |
| Average price | $0.0182 |
| Largest weekly change | +18.8% (Jun 19, 2024) |
| Weeks tracked | 153 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lisinopril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LISINOPRIL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL 10 MG TABLET, manufactured by Chartwell RX LLC, is $0.0181 per EA (NDC 62135064231), effective Sep 30, 2026.
How has the price of LISINOPRIL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for LISINOPRIL 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 153 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for LISINOPRIL 10 MG TABLET?
Since Nov 1, 2023, the NADAC for LISINOPRIL 10 MG TABLET has ranged from a low of $0.0156 (Jul 17, 2024) to a high of $0.0197 (Dec 13, 2023), with a median of $0.0184 per EA.
Are there cheaper alternatives to LISINOPRIL 10 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LISINOPRIL 10 MG TABLET, is $0.0176 per EA — about 3% below LISINOPRIL 10 MG TABLET.
Who manufactures LISINOPRIL 10 MG TABLET?
LISINOPRIL 10 MG TABLET (NDC 62135064231) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.